�鶹Ů��

President Trump began his second term Monday with a sweeping order aimed at reversing dozens of former President Biden’s top priorities, from regulations aimed at lowering health care costs, to coronavirus outreach, Affordable Care Act expansions, and protections against gender-based discrimination. (Owermohle, Wilkerson, Zhang and Lawrence, 1/20)

President Donald Trump has rescinded former President Joe Biden's executive order 14087, which was put in place to lower the cost of prescription drugs for Americans. Newsweek has reached out to the Trump transition team outside of regular working hours via email for comment. ... While the executive order has been rescinded, existing laws and regulations governing prescription drug pricing and Medicare and Medicaid policies remain in effect. However, the momentum toward developing new cost-saving measures as encouraged by the previous administration has now been disrupted. (McFall, 1/21)

The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. The Centers for Medicare and Medicaid Services negotiated prices for a first batch of drugs last year — something it could only do because of the Inflation Reduction Act, which passed in 2022. Those new prices go into effect in January 2026. (Lupkin, 1/17)

At least 24.2 million people purchased health insurance on the exchange marketplaces during open enrollment for 2025, the Centers for Medicare and Medicaid Services announced Friday. That tally surpasses a record set a year ago, as sign-ups for exchange plans accelerated mostly due to the enhanced subsidies enacted in 2021 and extended in 2022. (Young, 1/17)

A study by the Department of Veterans Affairs on the relationship between GLP-1 weight-loss drugs and 175 diseases and conditions supports a lot of what scientists already suspected about potential benefits, but contains a few surprises, too. The findings, published Monday in the journal Nature Medicine and based on an analysis of medical records from about 2.5 million patients in the VA system, support the idea that the medications might be able to help patients with Alzheimer’s disease and who are suffering from substance abuse involving alcohol, cannabis and narcotics. (Eunjung Cha, 1/20)

President Donald Trump said he will begin to make changes this week to a handful of health measures. In his inaugural speech in Washington on Monday, the 47th president promised to reverse actions taken against military members who declined to follow the Covid-19 vaccine mandate, which Congress repealed in 2023. Trump, despite largely focusing his address on immigration and the economy, also said his administration will reform the public health system. He noted chronic disease prevention and treatment as priorities, in line with the Make America Healthy Again agenda he shares with his pick to lead HHS, Robert F. Kennedy Jr. Trump also said he would change how public health agencies respond to disasters, noting flooding in North Carolina last year and the more recent wildfires in California. (Payne, 1/20)

The Trump administration inherited some big health policy headaches on Monday. And the nature of federal rules means it can't start from scratch on key questions about surprise billing, coverage of GLP-1s and prescribing controlled substances. (Goldman, 1/21)

�鶹Ů�� Health News: Days From Trump Inauguration, Journalists Weigh California, Federal Health Policies

�鶹Ů�� Health News senior correspondent Angela Hart discussed California Gov. Gavin Newsom’s health legacy on KVPR’s “Central Valley Daily” on Jan. 16 and on KQED’s “Forum” on Jan. 13. (1/18)